Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6572ff5df928fd17340eb2a8cb6d8502 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-403 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27 |
filingDate |
2012-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fcb742e4a489bd59b7257834afd3c6d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3333b346a6a1d49d19d6f6de8263933 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc5fdb123bea635f522746d59b87354b |
publicationDate |
2013-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
BR-102012010244-A2 |
titleOfInvention |
combination of 4- {3- [cis-hexahydro-cyclopenta [c] pyrrol-2 (1h) -yl] propoxy} benzamide and an acetylcholine esterase inhibitor, and pharmaceutical compositions containing the same |
abstract |
ASSOCIATION BETWEEN 4- {3-CIS-HEXA-HYDROCYCLOPENTA [C] PIRROL-2 (1H) -IL] PROPĂ XI} BENZAMIDE AND AN ACETILCO-LINAESTERASE INHIBITOR, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. The present invention relates to the combination of 4- {3- [cis-hexahydro-cyclopenta [c] pyrrol-2 (1H) -yl] propoxy} benzamide of formula (I): or an addition salt thereof with a pharmaceutically acceptable acid or base, and an acetylcholinesterase inhibitor. The invention further relates to medicaments. |
priorityDate |
2011-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |